Function of a HER2 VUS in colorectal cancer with APC mutations and its potential for HER2-targeted therapy

被引：0
|
作者：
Mitani, Yosuke [1 ]
Ohashi, Shinya [1 ]
Kikuchi, Osamu [1 ]
Muto, Manabu [1 ]
机构：
[1] Kyoto Univ, Dept Therapeut Oncol, Kyoto, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.378
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P34-6
引用
收藏
页码：S1455 / S1455
页数：1
相关论文
共 50 条
  • [1] HER2-targeted therapy in colorectal cancer: a comprehensive review
    Benli, Yeliz
    Arikan, Helin
    Akbulut-caliskan, Ozge
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2025,
  • [2] Activating HER2 mutations promote oncogenesis and resistance to HER2-targeted therapies in breast cancer
    Zuo, Wen-Jia
    Jiang, Yi-Zhou
    Yu, Ke-Da
    Shao, Zhi-Ming
    CANCER RESEARCH, 2015, 75
  • [3] Molecular Basis of HER2-Targeted Therapy for HER2-Positive Colorectal Cancer
    Yoshikawa, Ayumu
    Nakamura, Yoshiaki
    CANCERS, 2023, 15 (01)
  • [4] Plasma HER2 (ERBB2) Copy Number Predicts Response to HER2-targeted Therapy in Metastatic Colorectal Cancer
    Siravegna, Giulia
    Sartore-Bianchi, Andrea
    Nagy, Rebecca J.
    Raghav, Kanwal
    Odegaard, Justin I.
    Lanman, Richard B.
    Trusolino, Livio
    Marsoni, Silvia
    Siena, Salvatore
    Bardelli, Alberto
    CLINICAL CANCER RESEARCH, 2019, 25 (10) : 3046 - 3053
  • [5] Truncated HER2: implications for HER2-targeted therapeutics
    Zagozdzon, Radoslaw
    Gallagher, William M.
    Crown, John
    DRUG DISCOVERY TODAY, 2011, 16 (17-18) : 810 - 816
  • [6] Loss of HER2 after HER2-targeted treatment
    Ignatov, Tanja
    Gorbunow, Franceska
    Eggemann, Holm
    Ortmann, Olaf
    Ignatov, Atanas
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 175 (02) : 401 - 408
  • [7] Loss of HER2 after HER2-targeted treatment
    Tanja Ignatov
    Franceska Gorbunow
    Holm Eggemann
    Olaf Ortmann
    Atanas Ignatov
    Breast Cancer Research and Treatment, 2019, 175 : 401 - 408
  • [8] EFFICACY OF HER2-TARGETED THERAPY FOR HER2 POSITIVE BREAST CANCER ACCORDING TO HR STATUS
    Murata, T.
    Takahashi, M.
    Hayashida, T.
    Hirose, S.
    Jinno, H.
    Kitagawa, Y.
    BREAST, 2013, 22 : S104 - S104
  • [9] HER2-targeted therapy: an emerging strategy in advanced colorectal cancer
    La Salvia, Anna
    Lopez-Gomez, Victoria
    Garcia-Carbonero, Rocio
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (01) : 29 - 38
  • [10] Plasma HER2 (ERBB2) copy number to predict response to HER2-targeted therapy in metastatic colorectal cancer.
    Bardelli, Alberto
    Siravegna, Giulia
    Sartore-Bianchi, Andrea
    Nagy, Rebecca J.
    Mussolin, Benedetta
    Cassingena, Andrea
    Martino, Cosimo
    Lonardi, Sara
    Zagonel, Vittorina
    Leone, Francesco
    Amatu, Alessio
    Trusolino, Livio
    Odegaard, Justin
    Lanman, Richard B.
    Marsoni, Silvia
    Siena, Salvatore
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345